Humana Inc

Research Humana Inc (HUM) on Bullrun: valuation model: 41.6% overvalued, market cap USD 46.69B, P/E 41.6, dividend yield 0.9%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerHUM
• ExchangeNYSE
• CountryUnited States
• SectorHealthcare
• IndustryHealthcare Plans
• CurrencyUSD
• Valuation signal41.6% overvalued
• Market capUSD 46.69B
• P/E41.6
• Dividend yield0.9%
• Financial periodFY2025
• RevenueUSD 129.66B
• Revenue growth10.1%
• Net incomeUSD 1.19B
• Free cash flowUSD 375.00M

Valuation Snapshot

Bullrun's latest valuation model marks Humana Inc as 41.6% overvalued; latest market cap is USD 46.69B; P/E is 41.6; dividend yield is 0.9%.

About Humana Inc

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements;

Frequently asked questions

Is Humana Inc overvalued or undervalued?

Bullrun's valuation model currently marks Humana Inc as 41.6% overvalued.

What is Humana Inc's market cap?

Humana Inc's market capitalization is USD 46.69B.

What is Humana Inc's P/E ratio?

Humana Inc's price-to-earnings (P/E) ratio is 41.6.

Does Humana Inc pay a dividend?

Humana Inc has a dividend yield of 0.9%.

What does Humana Inc do?

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell.